Use of sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes mellitus and multiple cardiovascular risk factors: An Asian perspective and expert recommendations

Citation
Deerochanawong C, Chan SP, Matawaran BJ, et al. Diabetes Obes Metab 2019;21:2354–67.